Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dare I say conversion might be ...
I hope so too. I already posited that I think that S & L controls less of the company than Ronran's group. Now I think it is time for S & L to change its business model from that of toxic financier to that of investor in it, to quote Swartz in 2006, for "the long haul".

This latter should be doubly true if they expect to continue to hold 2 seats on the board.
Share
New Message
Please login to post a reply